Evimed
- Jiumei Gao
Jiumei Gao is an experienced analyst with a strong background in public health and data analysis. Currently employed at Evimed as an Analyst since January 2025, Jiumei previously served as a Senior Analyst and Analyst at Aquarius Population Health from July 2022 to December 2024. At the Royal College of Paediatrics and Child Health, Jiumei worked as a Data Analyst focusing on the National Paediatrics Diabetes Audit, analyzing patient data across hospitals in England and Wales. Prior experience includes a role as an Associate in Public Health with IOM - UN Migration, where analytical support was provided for global population mobility data, and a tenure as a Data Analyst/User Support with the British Red Cross. Jiumei has also engaged in various roles, including volunteer work, a research assistantship, and a grant writing assistantship, showcasing a diverse skill set. Educational qualifications include a Master's degree in Veterinary Epidemiology from the London School of Hygiene and Tropical Medicine and a Bachelor's degree in Anthropology from Colorado College.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
Evimed
At Evimed, we provide consultancy services to the pharmaceutical industry, focussing on technical excellence in evidence synthesis, health economics and outcomes research, real world evidence, and pricing. Our streamlined solutions to enable patients faster access to innovative medicines. Our focus is on delivering fit-for-purpose, rapid, high quality, and practical analytical solutions to maximize outcomes, minimize delays, and ultimately enable faster access for patients. Our services include: - Literature reviews & evidence synthesis: systematic, targeted, or rapid literature reviews; indirect treatment comparisons, network meta-analysis, matching-adjusted indirect treatment comparisons, multi-level network meta-regression - Health economic modelling: cost-effectiveness models, technical and strategic model QC and validation, advisory support with economic models, budget impact models, cost per response models, cost consequence models, PVTO, and all other bespoke models - Localisation of SLR, NMA, and HE deliverables: we have extensive experience performing localisations in many geographies including UK, France, Canada, Nordics, and Portugal. - Statistical data analysis: generation of health economic inputs including quality of life / utility analyses, survival analysis, treatment switching, analysis of adverse events & discontinuation, healthcare resource use, cost and disutility, post-hoc analysis of clinical trials, bespoke tailored methodological approaches to support publications. - Health technology assessment: advise on HTA & submission strategy, evaluation of expected HTA & reimbursement outcomes, identification of risks and mitigation strategies, assessment of development programme in line with competitors and agency expectations, assessment of early pipeline assets, trade-off assessments for milestone and launch decisions, and evaluation of business development opportunities.
